4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0000950170-25-080310
Director sold 1,392 shares at $7.25 ($10,096)
- Director acquired 4,800 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Altmeyer Anne Director | 2025-05-30 | Sale 10b5-1 | −1,392 | $7.25 | $10,096 | 1,391 | D |
| Altmeyer Anne Director | 2025-05-30 | Grant or award 10b5-1 | +4,800 | 6,191 | D | ||
| Derivatives | |||||||
| Altmeyer Anne Director | 2025-05-30 | Grant or award · Stock options (right to buy) 10b5-1 | +16,000 | 16,000 | D | ||
| Open-market sales · 1,392 sh · avg $7.25 · $10,096 | |||||||
Loading xslF345X05/ownership.xml…